AVTX
Avalo Therapeutics Inc
NASDAQ: AVTX · HEALTHCARE · BIOTECHNOLOGY
$13.20
+2.64% today
Updated 2026-04-29
Market cap
$317.21M
P/E ratio
—
P/S ratio
5,376.53x
EPS (TTM)
$-5.84
Dividend yield
—
52W range
$3 – $21
Volume
0.8M
Avalo Therapeutics Inc (AVTX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
—
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|